- Home
- SKYE vs ARBE Comparison
SKYE vs ARBE Comparison
Compare SKYE & ARBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- ARBE
- Stock Information
- Founded
- SKYE 2012
- ARBE 2015
- Country
- SKYE United States
- ARBE Israel
- Employees
- SKYE N/A
- ARBE N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- ARBE EDP Services
- Sector
- SKYE Health Care
- ARBE Technology
- Exchange
- SKYE Nasdaq
- ARBE Nasdaq
- Market Cap
- SKYE 94.0M
- ARBE 161.8M
- IPO Year
- SKYE N/A
- ARBE N/A
- Fundamental
- Price
- SKYE $2.73
- ARBE $3.00
- Analyst Decision
- SKYE Buy
- ARBE Strong Buy
- Analyst Count
- SKYE 6
- ARBE 2
- Target Price
- SKYE $18.67
- ARBE $3.00
- AVG Volume (30 Days)
- SKYE 167.7K
- ARBE 16.7M
- Earning Date
- SKYE 02-09-2025
- ARBE 03-06-2025
- Dividend Yield
- SKYE N/A
- ARBE N/A
- EPS Growth
- SKYE N/A
- ARBE N/A
- EPS
- SKYE N/A
- ARBE N/A
- Revenue
- SKYE N/A
- ARBE $1,016,000.00
- Revenue This Year
- SKYE N/A
- ARBE $1.56
- Revenue Next Year
- SKYE N/A
- ARBE $395.31
- P/E Ratio
- SKYE N/A
- ARBE N/A
- Revenue Growth
- SKYE N/A
- ARBE N/A
- 52 Week Low
- SKYE $2.25
- ARBE $1.40
- 52 Week High
- SKYE $19.41
- ARBE $5.09
- Technical
- Relative Strength Index (RSI)
- SKYE 37.40
- ARBE 58.15
- Support Level
- SKYE $2.31
- ARBE $2.67
- Resistance Level
- SKYE $3.04
- ARBE $3.99
- Average True Range (ATR)
- SKYE 0.30
- ARBE 0.61
- MACD
- SKYE 0.07
- ARBE 0.10
- Stochastic Oscillator
- SKYE 44.68
- ARBE 41.78
About SKYE Skye Bioscience Inc. Common Stock
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, USA, and others.